{
 "id": "epkh83nzf5",
 "slug": "love-is-panacea",
 "title": "Love is Panacea (治愈系恋人)",
 "updated": "2026-11-01",
 "topic_path": [
  {
   "id": "culture",
   "label": "Arts and culture",
   "api_url": "https://www.edgepedia.org/api/v1/topics/culture"
  },
  {
   "id": "culture.performance",
   "label": "Screen and stage",
   "api_url": "https://www.edgepedia.org/api/v1/topics/culture.performance"
  },
  {
   "id": "culture.performance.screen",
   "label": "Film and television",
   "api_url": "https://www.edgepedia.org/api/v1/topics/culture.performance.screen"
  },
  {
   "id": "culture.performance.screen.series",
   "label": "Series and fictional screen worlds",
   "api_url": "https://www.edgepedia.org/api/v1/topics/culture.performance.screen.series"
  },
  {
   "id": "culture.performance.screen.series.series_international_serials",
   "label": "International serial drama and telenovelas",
   "api_url": "https://www.edgepedia.org/api/v1/topics/culture.performance.screen.series.series_international_serials"
  },
  {
   "id": "culture.performance.screen.series.series_int_serials_east_asia",
   "label": "East Asian drama series",
   "api_url": "https://www.edgepedia.org/api/v1/topics/culture.performance.screen.series.series_int_serials_east_asia"
  },
  {
   "id": "culture.performance.screen.series.series_int_serials_east_asia.chinese_modern_drama",
   "label": "Chinese modern and contemporary drama",
   "api_url": "https://www.edgepedia.org/api/v1/topics/culture.performance.screen.series.series_int_serials_east_asia.chinese_modern_drama"
  },
  {
   "id": "culture.performance.screen.series.series_int_serials_east_asia.chinese_modern_drama.yr-1998-2023",
   "label": "Premiered 1998 to 2023",
   "api_url": "https://www.edgepedia.org/api/v1/topics/culture.performance.screen.series.series_int_serials_east_asia.chinese_modern_drama.yr-1998-2023"
  }
 ],
 "geo": [
  {
   "id": "geo.chn.t2021.culture.performance.screen.series.series_int_serials_east_asia.chinese_modern_drama",
   "label": "China · 2021 and later: Chinese modern and contemporary drama",
   "api_url": "https://www.edgepedia.org/api/v1/geo/geo.chn.t2021.culture.performance.screen.series.series_int_serials_east_asia.chinese_modern_drama",
   "path": [
    {
     "id": "geo.chn",
     "label": "China",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.chn"
    },
    {
     "id": "geo.chn.t2021",
     "label": "China · 2021 and later",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.chn.t2021"
    },
    {
     "id": "geo.chn.t2021.culture",
     "label": "Arts and culture",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.chn.t2021.culture"
    },
    {
     "id": "geo.chn.t2021.culture.performance",
     "label": "Screen and stage",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.chn.t2021.culture.performance"
    },
    {
     "id": "geo.chn.t2021.culture.performance.screen",
     "label": "Film and television",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.chn.t2021.culture.performance.screen"
    },
    {
     "id": "geo.chn.t2021.culture.performance.screen.series",
     "label": "Series and fictional screen worlds",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.chn.t2021.culture.performance.screen.series"
    },
    {
     "id": "geo.chn.t2021.culture.performance.screen.series.series_international_serials",
     "label": "International serial drama and telenovelas",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.chn.t2021.culture.performance.screen.series.series_international_serials"
    },
    {
     "id": "geo.chn.t2021.culture.performance.screen.series.series_int_serials_east_asia.chinese_modern_drama",
     "label": "Chinese modern and contemporary drama",
     "api_url": "https://www.edgepedia.org/api/v1/geo/geo.chn.t2021.culture.performance.screen.series.series_int_serials_east_asia.chinese_modern_drama"
    }
   ]
  }
 ],
 "excerpt": "Love is Panacea (治愈系恋人), also 爱情遇见达尔文, is a 2023 Chinese 34-episode medical romance on CCTV-8 and Youku, adapted from Ning Meng Yuyan's novel 治愈者, starring Luo Yunxi and Zhang Ruonan as a neurosurgeon and a Huntington's gene carrier.",
 "snippet": "Love is Panacea (治愈系恋人), also 爱情遇见达尔文, is a 2023 Chinese 34-episode medical romance on CCTV-8 and Youku, adapted from Ning Meng Yuyan's novel 治愈者, starring Luo Yunxi and Zhang Ruonan as a neurosurgeon and a Huntington's gene carrier.",
 "node": "culture.performance.screen.series.series_int_serials_east_asia.chinese_modern_drama.yr-1998-2023",
 "markdown": "# Love is Panacea (治愈系恋人)\n\n**Love is Panacea** (治愈系恋人) is a 2023 Chinese urban romantic medical drama starring [Luo Yunxi](https://www.edgepedia.org/luo-yunxi) and Zhang Ruonan, broadcast on CCTV-8 and Youku from November 2, 2023 in 34 episodes. Adapted from the novel *Zhi Yu Zhe* (治愈者) by Ning Meng Yuyan, it follows neurosurgeon Gu Yunzheng (顾云峥), who meets medical student [Su Wei](https://www.edgepedia.org/su-wei)'an (苏为安) during an aid mission in the fictional location of Lakaya and discovers she carries the gene for [Huntington's disease](https://www.edgepedia.org/huntingtons-disease), a rare and currently untreatable condition.<sup>[1](https://m.tvmao.com/drama/YWJjY20p)</sup><sup> • </sup><sup>[2](https://bkso.baidu.com/item/%E6%B2%BB%E6%84%88%E7%B3%BB%E6%81%8B%E4%BA%BA/63581740?fromModule=lemma_inlink)</sup>\n\n| Key fact | Detail |\n|---|---|\n| Original run | Premiered November 2, 2023 at 21:30 on CCTV-8 with simultaneous Youku streaming; 34 episodes<sup>[1](https://m.tvmao.com/drama/YWJjY20p)</sup><sup> • </sup><sup>[3](https://wapbaike.baidu.com/item/%E6%B2%BB%E6%84%88%E7%B3%BB%E6%81%8B%E4%BA%BA/63581740?fromModule=tashuo-article_bottom-lemma)</sup> |\n| Directors / writers | Fan Jinxuan and Mou Xiaojie (directors); Teng Xiaoneng and Shi Ruomin (screenwriters)<sup>[4](https://www.sohu.com/a/739723173_603687)</sup> |\n| Source material | The novel *Zhi Yu Zhe* (治愈者) by Ning Meng Yuyan, a medical doctor<sup>[5](https://k.sina.com.cn/article_3840084769_e4e30b2101901adur.html)</sup> |\n| Leads | Luo Yunxi as neurosurgeon Gu Yunzheng; Zhang Ruonan as Su Wei'an, a medical student who abandoned medicine after learning she carries the Huntington's disease gene<sup>[2](https://bkso.baidu.com/item/%E6%B2%BB%E6%84%88%E7%B3%BB%E6%81%8B%E4%BA%BA/63581740?fromModule=lemma_inlink)</sup><sup> • </sup><sup>[1](https://m.tvmao.com/drama/YWJjY20p)</sup> |\n| Ratings | CVB average 1.014% per episode, single-day peak 1.246%; Douban score 5.8<sup>[2](https://bkso.baidu.com/item/%E6%B2%BB%E6%84%88%E7%B3%BB%E6%81%8B%E4%BA%BA/63581740?fromModule=lemma_inlink)</sup><sup> • </sup><sup>[6](https://www.zaobao.com.sg/entertainment/story20240408-3265793)</sup> |\n| International release | Rakuten Viki (North America), WAVVE (South Korea), MyTV SUPER (Hong Kong), U-NEXT (Japan, from June 1, 2025)<sup>[2](https://bkso.baidu.com/item/%E6%B2%BB%E6%84%88%E7%B3%BB%E6%81%8B%E4%BA%BA/63581740?fromModule=lemma_inlink)</sup> |\n\n## Spoilers\n\n### Premise\n\nGu Yunzheng, an associate professor of neurosurgery, encounters Su Wei'an while performing a medical aid mission in Lakaya, a fictional, impoverished former French colony. She has given up medicine and works odd jobs as a tour guide, driver, seller of Moutai liquor, and translator. As the two move from bickering acquaintances to lovers, he realizes that her erratic behavior stems from carrying the gene for Huntington's disease. Confronting the situation of roughly 30,000 Huntington's patients and families in China with no available cure, Gu Yunzheng decides to abandon his promising career and devote himself to research on the disease.<sup>[1](https://m.tvmao.com/drama/YWJjY20p)</sup><sup> • </sup><sup>[7](https://www.sohu.com/a/734367199_116162)</sup>\n\nThe final episodes move toward the research effort and the couple's marriage: Su Wei'an volunteers as the first trial subject, a promising drug candidate fails when the patient Su Yuan dies of the disease, and Gu Yunzheng's investment searches are repeatedly rejected before the two marry in the finale.<sup>[1](https://m.tvmao.com/drama/YWJjY20p)</sup>\n\n## Source and development\n\nThe drama adapts *Zhi Yu Zhe* by Ning Meng Yuyan, who wrote the novel while working in a hospital after encountering patients with genetic diseases, giving the original a realist grounding.<sup>[5](https://k.sina.com.cn/article_3840084769_e4e30b2101901adur.html)</sup> In 2019, producer Teng Xiaoneng, who also became one of the screenwriters, recommended the novel to Hu Xin, the show's producer, chief producer, and one of its writers, who bought the rights immediately. Hu Xin has said she was drawn to the complete absence of love-triangle plotting in the story and to the original's reflections on life, and she positioned the show as a love story that carries a deeper message about illness and mortality.<sup>[7](https://www.sohu.com/a/734367199_116162)</sup>\n\nThe adaptation team treated the novel's plot as a structure missing bricks once it was made three-dimensional, working through motivation and logic scene by scene. The production consulted top Chinese neurosurgery specialists from the scripting stage onward to balance scientific and dramatic truth; viewers noted that the CT scans and instrument readouts shown on screen match the patients' conditions, and that the actors' surgical gestures are precise.<sup>[7](https://www.sohu.com/a/734367199_116162)</sup>\n\n## Production\n\nFilming ran from August 16 to December 8, 2022, nearly four months, which the production considered long for a modest-scale romance. The team scouted locations across Xinjiang, Ningxia, Sichuan, and Hainan before settling on a combination of Chengdu and Wanning, Hainan, to stand in for the fictional Lakaya. Managing a large cast of foreign extras proved difficult; when the production moved from Chengdu to Wanning, the actress playing Sakun's mother could not arrive, forcing a recast and re-editing of finished scenes. Post-production French dubbing for Zhang Ruonan was handled by Liu Xiaoyu, a voice actress with French study experience, working under the guidance of native speakers.<sup>[7](https://www.sohu.com/a/734367199_116162)</sup>\n\nThe series was produced by China Media Group and Youku with Xingkong Film and [Television](https://www.edgepedia.org/television), Mila Film and Television, Yuehua Entertainment, and Tianhao Shengshi, and was selected as a Sichuan provincial major cultural support project for 2022, the first supported project from the province to air on CCTV since the program began.<sup>[8](https://yule.360.com/detail/3463516)</sup>\n\n## Broadcast and reception\n\nThe show was retitled from its working name *Ai Qing Yu Jian Da Er Wen* (爱情遇见达尔文, literally \"Love Meets Darwin\") to *Zhi Yu Xi Lian Ren* on October 30, 2023, and premiered on November 2, 2023 at 21:30 on CCTV-8 with simultaneous streaming on Youku.<sup>[3](https://wapbaike.baidu.com/item/%E6%B2%BB%E6%84%88%E7%B3%BB%E6%81%8B%E4%BA%BA/63581740?fromModule=tashuo-article_bottom-lemma)</sup> Its first two episodes took the national number-one television rating, and CCTV-8's premiere night broke a 1% rating.<sup>[9](https://www.singtao.ca/6503002/2023-12-27/news-2023%E4%B8%8B%E5%8D%8A%E5%B9%B4%E5%8D%81%E5%A4%A7%E5%85%A7%E5%9C%B0%E5%81%B6%E5%83%8F%E5%8A%87%E7%B6%B2%E6%92%AD%E9%87%8F%E6%8E%92%E8%A1%8C%E6%A6%9C%EF%BC%9A%E4%BB%A5%E6%84%9B%E7%82%BA%E7%87%9F%EF%BC%8F%E5%BE%88%E6%83%B3%E5%BE%88%E6%83%B3%E4%BD%A0%EF%BC%8F%E6%88%91%E7%9A%84%E4%BA%BA%E9%96%93%E7%85%99%E7%81%AB/?variant=zh-cn)</sup><sup> • </sup><sup>[8](https://yule.360.com/detail/3463516)</sup> Over its run it topped several industry heat and market-share rankings, including Maoyan's all-network and drama heat lists and Lighthouse's positive-playback market share.<sup>[8](https://yule.360.com/detail/3463516)</sup> Across the run the show generated 471 entries on the Sina Weibo hot-search list, a main topic with over 780 million reads, and a Douyin topic with over 830 million plays.<sup>[8](https://yule.360.com/detail/3463516)</sup>\n\nCritical reception was mixed. CVB measured an average 1.014% rating per episode with a single-day peak of 1.246%.<sup>[2](https://bkso.baidu.com/item/%E6%B2%BB%E6%84%88%E7%B3%BB%E6%81%8B%E4%BA%BA/63581740?fromModule=lemma_inlink)</sup> The *Global Times* review praised the drama for using romance as an entry point to discuss life and death with a warm tone, and for the leads' mutual redemption arc.<sup>[2](https://bkso.baidu.com/item/%E6%B2%BB%E6%84%88%E7%B3%BB%E6%81%8B%E4%BA%BA/63581740?fromModule=lemma_inlink)</sup> By contrast, the Singapore newspaper *Lianhe Zaobao* recorded a Douban score of 5.8 and judged that the directing did not make the material engaging despite the promising premise.<sup>[6](https://www.zaobao.com.sg/entertainment/story20240408-3265793)</sup> Japanese-language coverage of the premiere reported viewer complaints about perceived lack of chemistry between the leads and skepticism about the medical framing.<sup>[10](https://www.recordchina.co.jp/comment/b923247-s36-c70-d0196.html)</sup>\n\n## Themes\n\nDirector Fan Jinxuan described warmth and healing as the show's core, with the central couple connected on three levels: teacher and student, work partners, and mutual redeemers. Gu Yunzheng carries wounds from a broken family, while Su Wei'an, from a loving family, distances herself from the people she cares about to avoid burdening them with her gene; the director framed their relationship as \"you heal my heart, I heal yours.\"<sup>[4](https://www.sohu.com/a/739723173_603687)</sup> Hu Xin described the intended emotional payoff as endorphin-like rather than a quick hormonal rush, and pointed to a sixth-episode scene in which a dying general holds a joyful living funeral as an example of the show's willingness to challenge conventional Chinese attitudes toward death.<sup>[7](https://www.sohu.com/a/734367199_116162)</sup> Baidu Baike describes the series as the first Chinese television drama centered on a rare disease.<sup>[2](https://bkso.baidu.com/item/%E6%B2%BB%E6%84%88%E7%B3%BB%E6%81%8B%E4%BA%BA/63581740?fromModule=lemma_inlink)</sup>\n\n## Distribution beyond mainland China\n\nThe drama aired on MyTV SUPER in Hong Kong in 2023, on Rakuten Viki in North America under the English title *Love is Panacea*, on WAVVE and other platforms in South Korea, and on U-NEXT in Japan from June 1, 2025 under the title *癒やしの恋人〜ロマンスの処方箋〜*. Later mainland reruns included CCTV Fengyun Theatre (November 14, 2024), CCTV-3 (December 2024), and CCTV First Theater (from February 18, 2025).<sup>[2](https://bkso.baidu.com/item/%E6%B2%BB%E6%84%88%E7%B3%BB%E6%81%8B%E4%BA%BA/63581740?fromModule=lemma_inlink)</sup><sup> • </sup><sup>[11](https://a-dra.com/drama/love-is-panacea/)</sup>\n\n## References\n\n1. [治愈系恋人剧情介绍（1-34全集）大结局, 电视猫](https://m.tvmao.com/drama/YWJjY20p)\n2. [治愈系恋人, 百度百科](https://bkso.baidu.com/item/%E6%B2%BB%E6%84%88%E7%B3%BB%E6%81%8B%E4%BA%BA/63581740?fromModule=lemma_inlink)\n3. [治愈系恋人（发行与定档信息）, 百度百科](https://wapbaike.baidu.com/item/%E6%B2%BB%E6%84%88%E7%B3%BB%E6%81%8B%E4%BA%BA/63581740?fromModule=tashuo-article_bottom-lemma)\n4. [对话《治愈系恋人》导演范金轩, 搜狐/烹小鲜](https://www.sohu.com/a/739723173_603687)\n5. [《治愈系恋人》打开现偶新格局｜对话总制片人胡昕, 新浪新闻](https://k.sina.com.cn/article_3840084769_e4e30b2101901adur.html)\n6. [从三对恋人关系看爱情怎么\"翻译\", 联合早报](https://www.zaobao.com.sg/entertainment/story20240408-3265793)\n7. [总制片人胡昕：大写的逻辑装进爱情的壳, 搜狐/影视独舌](https://www.sohu.com/a/734367199_116162)\n8. [川台星空影视出品 《治愈系恋人》首播周热度高涨, 360娱乐](https://yule.360.com/detail/3463516)\n9. [2023下半年十大内地偶像剧网播量排行榜, 星岛日报](https://www.singtao.ca/6503002/2023-12-27/news-2023%E4%B8%8B%E5%8D%8A%E5%B9%B4%E5%8D%81%E5%A4%A7%E5%85%A7%E5%9C%B0%E5%81%B6%E5%83%8F%E5%8A%87%E7%B6%B2%E6%92%AD%E9%87%8F%E6%8E%92%E8%A1%8C%E6%A6%9C%EF%BC%9A%E4%BB%A5%E6%84%9B%E7%82%BA%E7%87%9F%EF%BC%8F%E5%BE%88%E6%83%B3%E5%BE%88%E6%83%B3%E4%BD%A0%EF%BC%8F%E6%88%91%E7%9A%84%E4%BA%BA%E9%96%93%E7%85%99%E7%81%AB/?variant=zh-cn)\n10. [レオ・ローの最新ドラマ「治癒系恋人」、3つの点で視聴者が低評価, Record China](https://www.recordchina.co.jp/comment/b923247-s36-c70-d0196.html)\n11. [癒やしの恋人〜ロマンスの処方箋〜, U-NEXT 配信情報](https://a-dra.com/drama/love-is-panacea/)\n\n---\n*Topic: Encyclopedia › Arts and culture › Screen and stage › Film and television › Series and fictional screen worlds › International serial drama and telenovelas › East Asian drama series › Chinese modern and contemporary drama › Premiered 1998 to 2023*\n\n*Initially written Oct 3, 2026 · Reviewed: Oct 3, 2026; Oct 25, 2026 · Edited: Oct 15, 2026; Oct 25, 2026; Nov 1, 2026 · Last review: Oct 25, 2026*\n\n*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*\n\nLicense: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license\n",
 "same_as": [],
 "url": "https://www.edgepedia.org/love-is-panacea",
 "markdown_url": "https://www.edgepedia.org/love-is-panacea.md",
 "license": {
  "name": "Edgepedia Community License 1.0",
  "url": "https://www.edgepedia.org/edgepedia/license",
  "summary": "Free with credit, commercial use included. AI training is open to everyone. For other uses, organizations over USD 100M in revenue or 100M monthly users license separately.",
  "spdx": "LicenseRef-Edgepedia-Community-1.0"
 },
 "credit": "\"Love is Panacea (治愈系恋人)\", Edgepedia (EdgeChat), https://www.edgepedia.org/love-is-panacea. Edgepedia Community License 1.0.",
 "credit_md": "\"[Love is Panacea (治愈系恋人)](https://www.edgepedia.org/love-is-panacea)\", Edgepedia (EdgeChat), [https://www.edgepedia.org/love-is-panacea](https://www.edgepedia.org/love-is-panacea). [Edgepedia Community License 1.0](https://www.edgepedia.org/edgepedia/license).",
 "credit_html": "\"<a href=\"https://www.edgepedia.org/love-is-panacea\">Love is Panacea (治愈系恋人)</a>\", Edgepedia (EdgeChat), <a href=\"https://www.edgepedia.org/love-is-panacea\">https://www.edgepedia.org/love-is-panacea</a>. <a href=\"https://www.edgepedia.org/edgepedia/license\">Edgepedia Community License 1.0</a>.",
 "speakable": "Love is Panacea, also 爱情遇见达尔文, is a 2023 Chinese 34-episode medical romance on CCTV-8 and Youku, adapted from Ning Meng Yuyan's novel 治愈者, starring Luo Yunxi and Zhang Ruonan as a neurosurgeon and a Huntington's gene carrier."
}